Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 3.74
SIRO's Cash to Debt is ranked higher than
77% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.30 vs. SIRO: 3.74 )
SIRO' s 10-Year Cash to Debt Range
Min: 0.05   Max: No Debt
Current: 3.74

Equity to Asset 0.69
SIRO's Equity to Asset is ranked higher than
79% of the 303 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. SIRO: 0.69 )
SIRO' s 10-Year Equity to Asset Range
Min: -0.11   Max: 0.88
Current: 0.69

-0.11
0.88
Interest Coverage 53.52
SIRO's Interest Coverage is ranked higher than
75% of the 206 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.96 vs. SIRO: 53.52 )
SIRO' s 10-Year Interest Coverage Range
Min: 0.96   Max: 9999.99
Current: 53.52

0.96
9999.99
F-Score: 6
Z-Score: 6.48
M-Score: -2.09
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 19.62
SIRO's Operating margin (%) is ranked higher than
90% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.78 vs. SIRO: 19.62 )
SIRO' s 10-Year Operating margin (%) Range
Min: -66.23   Max: 35.85
Current: 19.62

-66.23
35.85
Net-margin (%) 14.58
SIRO's Net-margin (%) is ranked higher than
89% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.12 vs. SIRO: 14.58 )
SIRO' s 10-Year Net-margin (%) Range
Min: -64.92   Max: 45.97
Current: 14.58

-64.92
45.97
ROE (%) 13.03
SIRO's ROE (%) is ranked higher than
86% of the 302 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.58 vs. SIRO: 13.03 )
SIRO' s 10-Year ROE (%) Range
Min: -937.01   Max: 106.48
Current: 13.03

-937.01
106.48
ROA (%) 9.05
SIRO's ROA (%) is ranked higher than
88% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.35 vs. SIRO: 9.05 )
SIRO' s 10-Year ROA (%) Range
Min: -100.75   Max: 52.3
Current: 9.05

-100.75
52.3
ROC (Joel Greenblatt) (%) 64.22
SIRO's ROC (Joel Greenblatt) (%) is ranked higher than
93% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.02 vs. SIRO: 64.22 )
SIRO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -232.56   Max: 265.09
Current: 64.22

-232.56
265.09
Revenue Growth (%) 12.90
SIRO's Revenue Growth (%) is ranked higher than
89% of the 280 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.20 vs. SIRO: 12.90 )
SIRO' s 10-Year Revenue Growth (%) Range
Min: -23.4   Max: 80.6
Current: 12.9

-23.4
80.6
EBITDA Growth (%) 10.00
SIRO's EBITDA Growth (%) is ranked higher than
80% of the 235 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.70 vs. SIRO: 10.00 )
SIRO' s 10-Year EBITDA Growth (%) Range
Min: -30.1   Max: 84
Current: 10

-30.1
84
EPS Growth (%) 18.00
SIRO's EPS Growth (%) is ranked higher than
84% of the 236 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.10 vs. SIRO: 18.00 )
SIRO' s 10-Year EPS Growth (%) Range
Min: -73.5   Max: 263.4
Current: 18

-73.5
263.4
» SIRO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

SIRO Guru Trades in Q3 2013

Ron Baron 90,300 sh (+437.5%)
Jim Simons 413,700 sh (+158.56%)
Joel Greenblatt 73,036 sh (+61.16%)
Columbia Wanger 2,126,000 sh (+42.02%)
Manning & Napier Advisors, Inc 241,150 sh (+0.5%)
Steven Cohen Sold Out
Ruane Cunniff 2,954,817 sh (-0.04%)
Paul Tudor Jones 7,100 sh (-14.46%)
» More
Q4 2013

SIRO Guru Trades in Q4 2013

Bill Frels 5,000 sh (New)
Steven Cohen 6,822 sh (New)
Ron Baron 90,300 sh (unchged)
Paul Tudor Jones Sold Out
Columbia Wanger 2,119,000 sh (-0.33%)
Ruane Cunniff 2,931,923 sh (-0.77%)
Manning & Napier Advisors, Inc 233,180 sh (-3.3%)
Jim Simons 189,000 sh (-54.31%)
Joel Greenblatt 12,685 sh (-82.63%)
» More
Q1 2014

SIRO Guru Trades in Q1 2014

Paul Tudor Jones 3,200 sh (New)
Ron Baron 90,300 sh (unchged)
Steven Cohen Sold Out
Joel Greenblatt Sold Out
Manning & Napier Advisors, Inc Sold Out
Jim Simons Sold Out
Ruane Cunniff 2,910,454 sh (-0.73%)
Columbia Wanger 1,609,500 sh (-24.04%)
Bill Frels 3,000 sh (-40%)
» More
Q2 2014

SIRO Guru Trades in Q2 2014

Chuck Royce 1,040 sh (New)
Jeremy Grantham 43,800 sh (New)
Bill Frels Sold Out
Ruane Cunniff 2,851,162 sh (-2.04%)
Ron Baron 81,200 sh (-10.08%)
Paul Tudor Jones 2,600 sh (-18.75%)
Columbia Wanger 1,218,000 sh (-24.32%)
» More
» Details

Insider Trades

Latest Guru Trades with SIRO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-03-31 Sold Out 0.02%$67.35 - $75.19 $ 78.0210%0
Joel Greenblatt 2013-12-31 Reduce -82.63%0.13%$66.45 - $72.61 $ 78.0212%12685
Joel Greenblatt 2013-09-30 Add 61.16%0.06%$64.77 - $72.3 $ 78.0216%73036
Ron Baron 2013-09-30 Add 437.5%0.02%$64.77 - $72.3 $ 78.0216%90300
Mariko Gordon 2013-06-30 Sold Out 0.15%$62.82 - $75.41 $ 78.0211%0
Joel Greenblatt 2013-06-30 Add 576.09%0.11%$62.82 - $75.41 $ 78.0211%45318
Joel Greenblatt 2012-12-31 Reduce -20.65%0.01%$55.02 - $63.08 $ 78.0231%7043
Ron Baron 2012-09-30 New Buy0.01%$41.78 - $57.16 $ 78.0258%16800
Lee Ainslie 2012-06-30 Sold Out 0.79%$41.08 - $51.93 $ 78.0267%0
Ruane Cunniff 2012-06-30 Add 15.55%0.15%$41.08 - $51.93 $ 78.0267%2922154
Joel Greenblatt 2012-06-30 New Buy0.04%$41.08 - $51.93 $ 78.0267%11092
Lee Ainslie 2012-03-31 Reduce -40.97%0.45%$43.15 - $52.38 $ 78.0273%1071713
Lee Ainslie 2011-12-31 New Buy1.1%$39.73 - $49.43 $ 78.0277%1815539
Ruane Cunniff 2011-12-31 Add 3995.82%0.94%$39.73 - $49.43 $ 78.0277%2523229
Ruane Cunniff 2011-09-30 New Buy0.03%$39.55 - $56 $ 78.0264%61605
Joel Greenblatt 2011-06-30 Sold Out 0.08%$50.41 - $57.07 $ 78.0247%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 25.60
SIRO's P/E(ttm) is ranked higher than
82% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 34.10 vs. SIRO: 25.60 )
SIRO' s 10-Year P/E(ttm) Range
Min: 7.46   Max: 766.86
Current: 25.6

7.46
766.86
P/B 3.43
SIRO's P/B is ranked higher than
68% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.17 vs. SIRO: 3.43 )
SIRO' s 10-Year P/B Range
Min: 0.84   Max: 11.56
Current: 3.43

0.84
11.56
P/S 3.73
SIRO's P/S is ranked higher than
66% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.03 vs. SIRO: 3.73 )
SIRO' s 10-Year P/S Range
Min: 0.74   Max: 7.44
Current: 3.73

0.74
7.44
PFCF 47.36
SIRO's PFCF is ranked higher than
80% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 127.16 vs. SIRO: 47.36 )
SIRO' s 10-Year PFCF Range
Min: 9.29   Max: 99.96
Current: 47.36

9.29
99.96
EV-to-EBIT 18.78
SIRO's EV-to-EBIT is ranked higher than
80% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.10 vs. SIRO: 18.78 )
SIRO' s 10-Year EV-to-EBIT Range
Min: 9.1   Max: 92.6
Current: 18.78

9.1
92.6
PEG 2.29
SIRO's PEG is ranked higher than
92% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. SIRO: 2.29 )
SIRO' s 10-Year PEG Range
Min: 0.34   Max: 16.43
Current: 2.29

0.34
16.43
Shiller P/E 37.11
SIRO's Shiller P/E is ranked higher than
83% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. SIRO: 37.11 )
SIRO' s 10-Year Shiller P/E Range
Min: 12.2   Max: 337.5
Current: 37.11

12.2
337.5
Current Ratio 2.72
SIRO's Current Ratio is ranked higher than
71% of the 238 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.92 vs. SIRO: 2.72 )
SIRO' s 10-Year Current Ratio Range
Min: 0.75   Max: 8.27
Current: 2.72

0.75
8.27
Quick Ratio 2.18
SIRO's Quick Ratio is ranked higher than
77% of the 238 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.84 vs. SIRO: 2.18 )
SIRO' s 10-Year Quick Ratio Range
Min: 0.17   Max: 7.7
Current: 2.18

0.17
7.7

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 12.93
SIRO's Price/Tangible Book is ranked higher than
62% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.22 vs. SIRO: 12.93 )
SIRO' s 10-Year Price/Tangible Book Range
Min: 1   Max: 198.23
Current: 12.93

1
198.23
Price/DCF (Projected) 1.52
SIRO's Price/DCF (Projected) is ranked higher than
86% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.31 vs. SIRO: 1.52 )
SIRO' s 10-Year Price/DCF (Projected) Range
Min: 0.54   Max: 8.57
Current: 1.52

0.54
8.57
Price/Median PS Value 1.10
SIRO's Price/Median PS Value is ranked higher than
75% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. SIRO: 1.10 )
SIRO' s 10-Year Price/Median PS Value Range
Min: 0.04   Max: 2.2
Current: 1.1

0.04
2.2
Price/Peter Lynch Fair Value 3.27
SIRO's Price/Peter Lynch Fair Value is ranked higher than
89% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. SIRO: 3.27 )
SIRO' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.48   Max: 30.26
Current: 3.27

0.48
30.26
Price/Graham Number 3.86
SIRO's Price/Graham Number is ranked higher than
77% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.07 vs. SIRO: 3.86 )
SIRO' s 10-Year Price/Graham Number Range
Min: 0.7   Max: 14.32
Current: 3.86

0.7
14.32
Earnings Yield (Greenblatt) 5.30
SIRO's Earnings Yield (Greenblatt) is ranked higher than
72% of the 260 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. SIRO: 5.30 )
SIRO' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.1   Max: 10.9
Current: 5.3

1.1
10.9
Forward Rate of Return (Yacktman) 10.43
SIRO's Forward Rate of Return (Yacktman) is ranked higher than
85% of the 258 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.55 vs. SIRO: 10.43 )
SIRO' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -6.2   Max: 53.8
Current: 10.43

-6.2
53.8

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:RXT.Germany
Sirona Dental Systems, Inc. was founded in 1992 and completed an initial public offering of its common stock on July 1, 1997. The Company is a manufacturer of high-quality, technologically-advanced dental equipment, and is focused on developing, manufacturing and marketing innovative solutions for dentists around the world. The Company provides a range of technologically advanced products in each of its four product segments: Dental CAD/CAM Systems; Imaging Systems; Treatment Centers; and Instruments. The Company markets its products globally to dental practices, clinics and laboratories through an international network of distributors. The global dental market encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Recent technological advancements in the dental equipment industry include 3D radiography, digital radiography, CAD/CAM technology, intra oral cameras and periodontal instruments. The market it serves comprises the whole working environment of a dentist or dental technician, including the dentist's chair, lights, imaging systems and dental CAD/CAM systems, instruments, as well as practice furniture and other dental or lab-based systems. Dental CAD/CAM Systems address the worldwide market for dental restorations, which includes several types of restorations, such as inlays, onlays, veneers, crowns, bridges, copings and bridge frameworks made from ceramic, metal or composite blocks. The Company has developed a range of imaging systems for 2D and 3D, panoramic and intra-oral applications that allow the dentist to accommodate the patient in a more efficient manner. Treatment Centers comprise a range of products from basic dentist chairs to sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, as well as specialist centers used in preventative treatment and for training purposes. In July 2008, the Company launched its new TENEO Treatment Center, which combines technology with a timeless design that provides both patient and dentist with the ultimate in convenience and comfort. The Company offers a range of instruments, including handheld and power-operated handpieces for cavity preparation, endodontics, periodontology and prophylaxis. The instruments are supplemented by multi-function tips, supply and suction hoses, as well as care and hygiene systems for instrument preparation. Its product information is actively made available to business publications, dentists, journals, professional organizations and dental schools, and its website. Sirona distributes its products globally to dental practices, clinics and laboratories through an international network of more than 350 distributors. The Company's registered trademarks include, 'Sirona,' 'CEREC,' 'Orthophos,' 'Heliodent,' 'inLab,' 'CDR,' and 'Schick'. It competes with different companies which include large international companies as well as smaller companies that comp
» More Articles for SIRO

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BWEN, DDMG, ZHNE, ENZ, SIRO Nov 28 2011 
Weekly CEO Buys Highlight: KMI, VGR, SIRO, PNK, MASI Nov 27 2011 
Sirona Dental Systems Inc. Reports Operating Results (10-K) Nov 18 2010 
Sirona Dental Systems Inc. (siro) Dir. Exec. VP. COO US Op Jeffrey Slovin sells 250,000 Shares Feb 23 2010 
Sirona Dental Systems Inc. (siro) Dir. Exec. VP. COO US Op Jeffrey Slovin sells 250,000 Shares Dec 17 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-K) Dec 04 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) Jul 31 2009 
Sirona Reports Fiscal 2009 Third Quarter and Year-to-Date Results Jul 31 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) May 06 2009 
Sirona Dental Systems Inc. Reports Operating Results (10-Q) Feb 05 2009 

More From Other Websites
SIRONA DENTAL SYSTEMS, INC. Financials Aug 15 2014
Sirona Dental Systems Q3 Earnings & Revenues Beat Estimates Aug 11 2014
Sirona's EPS growth quickens Aug 08 2014
Sirona's EPS Growth Accelerates On Instrument Sales Aug 08 2014
Barbarian At The Gate: Sirona Dental Systems (SIRO) Aug 08 2014
SIRONA DENTAL SYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 08 2014
Q3 2014 Sirona Dental Systems Earnings Release - Before Market Open Aug 08 2014
Sirona Reports Record Fiscal 2014 Third Quarter Results Aug 08 2014
Wall Street Transcript Interview with Bob McNamara, the Executive Vice President and CFO of LDR... Aug 01 2014
Sirona to Report Third Quarter Fiscal 2014 Results on August 8th Jul 25 2014
AngioDynamics (ANGO) Crumbles: Stock Falls 7.4% Jul 25 2014
Sirona Dental Systems (SIRO) Hits New Lifetime High Jul 07 2014
Sirona balances innovation and ease of use with release of new CEREC 4.3 software Jun 27 2014
Sirona Dental Hits New 52-Week High Jun 27 2014
New Lifetime High Reached: Sirona Dental Systems (SIRO) Jun 27 2014
Will This Price Target Increase Help Sirona Dental Systems (SIRO) Stock Today? Jun 23 2014
Sirona Dental price target raised to $93 from $85 at Jefferies Jun 23 2014
New Lifetime High Reached: Sirona Dental Systems (SIRO) Jun 16 2014
Henry Schein Acquires Sirona Direct Jun 04 2014
SIRONA DENTAL SYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jun 03 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK